Jump to content

Rosacea

From Wikipedia
rosacea
class of disease
Subclass ofskin disease, disease Edit
Health specialtydermatology Edit
WordLift URLhttp://data.medicalrecords.com/medicalrecords/healthwise/rosacea Edit
ICD-9-CM695.3 Edit

Rosacea be a long-term skin condition wey typically dey affect de face.[1][2] E dey result in redness, pimples, swelling, den small den superficial dilated blood vessels.[1] Often, de nose, cheeks, forehead, den chin most be involved.[2] A red, enlarged nose fi occur in severe disease, a condition dem know as rhinophyma.[2]

De cause of rosacea be unknown.[1] Risk factors dey include a family history of de condition.[2] Factors wey potentially fi worsen de condition dey include heat, exercise, sunlight, cold, spicy food, alcohol, menopause, psychological stress, anaa use of steroid cream on de face.[3] Diagnosis dey base on symptoms.[1]

While no be curable, treatment usually dey improve symptoms.[2] Treatment typically be plus metronidazole, doxycycline, minocycline, anaa tetracycline.[4] Wen de eyes be affected, azithromycin eye drops fi help.[5] Oda treatments plus tentative benefit dey include brimonidine cream, ivermectin cream, den isotretinoin.[4] Dermabrasion anaa laser surgery sanso fi be used.[2] De use of sunscreen typically be recommended.[2]

Rosacea dey affect between 1% den 10% of people.[1] Those affected most often be 30 to 50 years old den female.[1] Fair-skinned people dey seem to be more commonly affected.[6] Na dem describe de condition insyd The Canterbury Tales insyd de 1300s, den possibly as early as de 200s BC by Theocritus.[7][8]

References

[edit | edit source]
  1. 1 2 3 4 5 6 Tüzün Y, Wolf R, Kutlubay Z, Karakuş O, Engin B (February 2014). "Rosacea and rhinophyma". Clinics in Dermatology. 32 (1): 35–46. doi:10.1016/j.clindermatol.2013.05.024. PMID 24314376.
  2. 1 2 3 4 5 6 7 "Questions and Answers about Rosacea". www.niams.nih.gov (in English). April 2016. Archived from the original on 13 May 2017. Retrieved 5 June 2017.
  3. Stein S (2020). Rosacea. Stern S.C., & Cifu A.S., & Altkorn D(Eds.), Symptom to Diagnosis: An Evidence-Based Guide, 4e. McGraw-Hill Education.
  4. 1 2 van Zuuren, EJ; Fedorowicz, Z (September 2015). "Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments". The British Journal of Dermatology. 173 (3): 651–62. doi:10.1111/bjd.13956. PMID 26099423. S2CID 41303286.
  5. "Rosacea First choice treatments". Prescrire International. 182: 126–128. May 2017. Archived from the original on 10 September 2017.
  6. Rainer BM, Kang S, Chien AL (2017). "Rosacea: Epidemiology, pathogenesis, and treatment". Dermatoendocrinol. 9 (1) e1361574. doi:10.1080/19381980.2017.1361574. PMC 5821167. PMID 29484096.
  7. Zouboulis, Christos C.; Katsambas, Andreas D.; Kligman, Albert M. (2014). Pathogenesis and Treatment of Acne and Rosacea (in English). Springer. p. XXV. ISBN 978-3-540-69375-8. Archived from the original on 10 September 2017.
  8. Schachner, Lawrence A.; Hansen, Ronald C. (2011). Pediatric Dermatology E-Book (in English). Elsevier Health Sciences. p. 827. ISBN 978-0-7234-3665-2. Archived from the original on 10 September 2017.
[edit | edit source]